Further studies in a larger cohort could confirm whether the limited efficacy of early EVL initiation to counteract the cytotoxic response mediated by memory CD8+ T and NK cells reported here might be useful for developing a potent viral immune response in those HT patients. This evidence concerns the gene CD8A and hematocrit.